Journal profile · Medicine-Medicine (all)
Postepy biochemii
ISSN 0032-5422 · Polskie Towarzystwo Biochemiczne
FollowGet an email when its zone, impact factor or warning status changes
Postepy biochemii: fully open access; median 60 days to acceptance (51 articles, last 24 months); 41 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Postepy biochemii is published by Polskie Towarzystwo Biochemiczne. By OpenAlex counts of its recent articles, its largest topics are Biochemical and Molecular Research, History of Science and Medicine and RNA and protein synthesis mechanisms, together about 24.1% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Medicine-Medicine (all)
Main research topics OpenAlex counts of recent articles; shares are approximate
- Biochemical and Molecular ResearchBiochemistry, Genetics and Molecular Biology9.1%
- History of Science and MedicineArts and Humanities7.8%
- RNA and protein synthesis mechanismsBiochemistry, Genetics and Molecular Biology7.2%
- Biographical and Historical AnalysisArts and Humanities5.7%
- Protein Structure and DynamicsBiochemistry, Genetics and Molecular Biology5.1%
- Plant biochemistry and biosynthesisBiochemistry, Genetics and Molecular Biology5%
- Bacterial Genetics and BiotechnologyBiochemistry, Genetics and Molecular Biology4.9%
- DNA and Nucleic Acid ChemistryBiochemistry, Genetics and Molecular Biology4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Biochemistry, Genetics and Molecular Biology (miscellaneous) | Q4 | 128/144 | — |
| Biochemistry | Q4 | 423/448 | — |
| Molecular Biology | Q4 | 396/414 | — |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
- CiteScore 2026-06
- 0.7LetPub ·
- SJR 2026-06
- 0.25LetPub ·
- SNIP 2026-06
- 0.1LetPub ·
- h-index
- 15OpenAlex ·
- i10-index
- 26OpenAlex ·
- 2-year mean citedness
- 0.86OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 1,032 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 23 | 23 | 122 |
| 2025 | 41 | 41 | 171 |
| 2024 | 61 | 61 | 147 |
| 2023 | 31 | 31 | 145 |
| 2022 | 46 | 46 | 163 |
| 2021 | 47 | 47 | 135 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
60 daysMedian, submission to acceptance · P25–P75 48 days – 67 days
- Acceptance to online
- median 37 days (51 articles)
- Submission to online
- median 105 days
- Sample
- 51 articles with submission and acceptance dates (62 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Before you submit
Four checks before submitting to Postepy biochemii
- 1ScopeRecent output centres on Biochemical and Molecular Research, History of Science and Medicine.Check scope
- 2Article type and formatPrepare text, figures and references as the author guidelines ask.
- 3English languagePolish grammar and academic style before you submit: it lowers the risk of rejection for language and improves your chances of acceptance.
- 4Expected review time60 days · Median, submission to acceptance · 51 articles, last 24 months · PubMedReview data
The checks are built from this page's data.
Profile
Publication details and official links
- Publisher
- Polskie Towarzystwo Biochemiczne
- ISSN
- 0032-5422
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Postepy biochemii
How long does peer review take at Postepy biochemii?
Based on the dates recorded on 51 articles published between November 2024 and November 2026 (the last 24 months), the median time from submission to acceptance is 60 days (interquartile range 48–67 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Postepy biochemii?
According to LetPub and DOAJ records, Postepy biochemii is indexed in Scopus.
Is Postepy biochemii open access, and what is the APC?
Postepy biochemii is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .